Your browser doesn't support javascript.
loading
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort.
Grabar, Sophie; Potard, Valérie; Piroth, Lionel; Abgrall, Sophie; Bernard, Louis; Allavena, Clotilde; Caby, Fabienne; de Truchis, Pierre; Duvivier, Claudine; Enel, Patricia; Katlama, Christine; Khuong, Marie-Aude; Launay, Odile; Matheron, Sophie; Melica, Giovanna; Melliez, Hugues; Meynard, Jean-Luc; Pavie, Juliette; Slama, Laurence; Bregigeon, Sylvie; Tattevin, Pierre; Capeau, Jacqueline; Costagliola, Dominique.
Affiliation
  • Grabar S; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital St Antoine, F75012, Paris, France.
  • Potard V; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F75013, Paris, France.
  • Piroth L; Infectious Diseases Department, CHU Dijon, and Inserm CIC 1432 Université de Bourgogne, Dijon, France.
  • Abgrall S; AP-HP, Hôpital Béclère, Service de Médecine Interne, Clamart, and Université Paris-Saclay, CESP INSERM U1018, Le Kremlin-Bicêtre, France.
  • Bernard L; Université de Tours, Tours, France.
  • Allavena C; Infectious Diseases Department, INSERM EA1413, CHU de Nantes, Nantes, France.
  • Caby F; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F75013, Paris, France.
  • de Truchis P; Unité VIH-IST, Service d'Immuno-Hematologie, Hôpital Victor Dupouy, Argenteuil, France.
  • Duvivier C; AP-HP Hôpital Raymond Poincaré, Université Paris-Saclay, Garches, France.
  • Enel P; AP-HP, Hôpital Necker-Enfants Malades, Service de Maladies Infectieuses et Tropicales, Centre d'Infectiologie Necker-Pasteur, Paris, France.
  • Katlama C; IHU Imagine, Paris, France.
  • Khuong MA; Institut Cochin-CNRS 8104-INSERM U1016, Université Paris Cité, Paris, France.
  • Launay O; Institut Pasteur, Centre Médical de l'Institut Pasteur, Paris, France.
  • Matheron S; Assistance Publique-Hôpitaux de Marseille, Public Health Department, Marseille, and Aix-Marseille University, CEReSS, Health Service Research and Quality of Life Center, Marseille, France.
  • Melica G; AP-HP, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, and AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Melliez H; Hôpital Delafontaine, Saint-Denis, France.
  • Meynard JL; Université Paris-Cité, AP-HP, Hôpital Cochin, INSERM, CIC 1417, Paris, France.
  • Pavie J; Service de Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude Bernard, GHU Paris Nord, AP-HP, Paris, France.
  • Slama L; Clinical Immunology and Infectious Diseases Department, Henri Mondor Hospital, Creteil, France.
  • Bregigeon S; Médecine Interne, Hôpital Riaumont, 62 800, Liévin, France.
  • Tattevin P; AP-HP, Department of Infectious Diseases, Saint-Antoine Hospital, Paris, France.
  • Capeau J; Department of Immunology and Infectious Diseases, AP-HP Hôtel-Dieu, Paris, France.
  • Costagliola D; Infectious Diseases Unit, Hôtel Dieu Hospital, APHP, Paris, France.
J Antimicrob Chemother ; 78(3): 757-768, 2023 03 02.
Article in En | MEDLINE | ID: mdl-36683307
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome / Anti-HIV Agents Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome / Anti-HIV Agents Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article